Optimized MP MVA refractive technique for better visual performance
Official title: Clinical Evaluation of Visual Outcomes in LEAP, HIGH, COMP and VISN Extension Cohort
Run by Hoya Surgical Optics, Inc. · NCT07595432 · Data updated 2026-11-12
This study tests whether the optimized Maximum Plus Maximum Visual Acuity method helps people with prior IOL implants see better at intermediate distances.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Hoya Surgical Optics, Inc. Industry-sponsored |
| Locations | 1 site (Manila) |
| Status | Recruiting |
| Started | May 13, 2026 |
| Main results expected | November 30, 2026 |
| Study ends | November 30, 2026 |
| Registry record updated | June 4, 2026 |
| Trial ID | NCT07595432 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with prior intraocular lens implantation who meet the inclusion criteria and have clear media, able to consent, and participate in required visits.
✕Probably not a fit
Patients with corrected distance acuity worse than 0.2 logMAR (20/32) or those with conditions likely to affect outcomes may receive no demonstrated benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, multicenter, non-interventional observational study that compares visual outcomes between two sites while masking examiners. It includes patients previously enrolled in Hoya studies or previously implanted with non-toric monofocal IOLs, focusing on distance-corrected intermediate visual acuity. The study aims to demonstrate non-inferiority of mean DCIVA between Site 1 and Site 2. Participation does not involve an active treatment, and data are collected from existing IOL recipients during routine follow-up visits. The design supports exploratory sub-analysis for eyes with specific prior IOL histories.
Why it matters
Potential benefit: If successful, the findings could support the use of the optimized MP MVA technique to maintain or improve intermediate vision in patients with prior IOL implants.
How similar studies have gone: Prior studies in this area have shown mixed results, with some demonstrating non-inferiority or comparable outcomes in similar refractive assessments.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Main study: 1. Previously implanted with intraocular lens through 2 previous IOL studies; 2. Clear intraocular media with no clinically significant opacity, in the investigator's judgment, that would affect visual acuity; 3. Able to provide informed consent and complete all required study procedures. Exploratory sub-study: 1\. Additional inclusion criteria: Pseudophakic eyes implanted with one of the IOLs in one eye from 3 previous IOL studies Exclusion Criteria: Main study: 1. Corrected distance visual acuity (CDVA) worse than 0.2 logMAR (or 20/32 Snellen) 2. Subjects with ongoing medical conditions or treatment that might impact outcomes during the study visit as determined by the investigator. Exploratory sub-study: 1\. Additional exclusion criteria: Pseudophakic eyes with oblique residual astigmatism.
Where it's running
-
Peregrine Eye Laser Institute
Manila, Philippines Recruiting
Study contacts
- Study coordinator: Srividhya Medical Monitor
- Email: srividhya.vilupuru@hoya.com
- Phone: +1-909-680-3900
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating long-term visual outcomes of pediatric cataract surgery
This study is testing how well cataract surgery works for children over time and looking at factors that might affect their vision.
-
Evaluating long-term visual outcomes after cataract surgery in high myopia patients
This study looks at how cataract surgery affects vision over time in people with severe nearsightedness compared to those with regular age-related cataracts.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.